PR NewswireBOSTON, March 3, 2025
Frank Chan joins Haemonetics as Executive Vice President, Chief Operating Officer; Roy Galvin named Executive Vice Preside
PR NewswireBOSTON, Feb. 24, 2025
BOSTON, Feb. 24, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, w
Haemonetics shares have been trading at more appealing levels after a reduction in full-year sales guidance. Check out my recommendation for HAE stock.
The stock of Haemonetics Corporation (HAE) experienced a notable decline, dropping 5.06% to $59.80 per share. The trading volume reached 1.465 million shares, w
Haemonetics (HAE) stock slips after Bank of America downgrade citing concerns over revised FY25 outlook and impact of Trump tariffs on Canada and Mexico. Read more here.
Learn about Haemonetics Corporation's recent stock drop after missing Q3 revenue estimates and how the company is adjusting its guidance for the future.
Earnings Call Insights: Haemonetics Corporation (NYSE:HAE) Q3 2025Management ViewCEO Christopher Simon reported third-quarter revenue of $349 million, a 4%...
PR NewswireNEW YORK, Jan. 27, 2025
NEW YORK, Jan. 27, 2025 /PRNewswire/ --Oldest and largest small-cap closed-end fundAverage weekly trading volume of appr
NEW YORK, Jan. 27, 2025 /PRNewswire/ -- Oldest and largest small-cap closed-end fundAverage weekly trading volume of approximately 1,524,979 sharesFund's adviser has more than 50 years of small- and micro-cap
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please ...
PR NewswireBOSTON, Dec. 3, 2024
BOSTON, Dec. 3, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on de
Oldest and largest small-cap closed-end fundAverage weekly trading volume of approximately 1,146,244 sharesFund's adviser has more than 50 years of small- and micro-cap investment experienceNEW YORK, Oct. 28, 2024
Discover the booming blood screening market from 2024 to 2031, as innovative technologies and rising health awareness drive demand across diverse product...
Blood collection industry is projected to witness a CAGR of 6.9% during the period 2024-2032. This growth can be attributed to advancements in blood...